# A Clinical Trial of AK152 in Healthy Volunteers and Patients With Alzheimer' s Disease

> **NCT07301502** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Akeso** · enrollment: 108 (estimated)

## Conditions studied

- Alzheimer' s Disease

## Interventions

- **DRUG:** AK152
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07301502
- **Lead sponsor:** Akeso
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12
- **Primary completion:** 2027-06
- **Final completion:** 2027-06
- **Target enrollment:** 108 (ESTIMATED)
- **Last updated:** 2025-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07301502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07301502, "A Clinical Trial of AK152 in Healthy Volunteers and Patients With Alzheimer' s Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07301502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*